13 days ago · Brazil
Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral under global licence
What's happening
SignalsMonitor is following this as a general story. Premium Times Nigeria is the outlet attached so far. The reports are tied to Brazil. The first report grouped here was at 4 Oct 2026, 10:03 UTC. The headline in use is “Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral under global licence”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
The selected manufacturers are from Brazil, China, India, Indonesia, Malaysia, Nigeria, Uganda, Ukraine and Vietnam. The post Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral under global licence appeared first on Premium Times Nigeria.
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by Premium Times Nigeria
Nigerian drugmaker Fidson selected to manufacture generic influenza antiviral under global licence
Reported by 1 outlet
- Premium Times Nigeria